Sweat lactate sensor for detecting anaerobic threshold in heart failure: a prospective clinical trial (LacS-001).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 Aug 2024
Historique:
received: 15 09 2023
accepted: 12 08 2024
medline: 17 8 2024
pubmed: 17 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

A simple method for determining the anaerobic threshold in patients with heart failure (HF) is needed. This prospective clinical trial (LacS-001) aimed to investigate the safety of a sweat lactate-monitoring sensor and the correlation between lactate threshold in sweat (sLT) and ventilatory threshold (VT). To this end, we recruited 50 patients with HF and New York Heart Association functional classification I-II (mean age: 63.5 years, interquartile range: 58.0-72.0). Incremental exercise tests were conducted while monitoring sweat lactate levels using our sensor. sLT was defined as the first steep increase in lactate levels from baseline. Primary outcome measures were a correlation coefficient of ≥ 0.6 between sLT and VT, similarities as assessed by the Bland-Altman analysis, and standard deviation of the difference within 15 W. A correlation coefficient of 0.651 (95% confidence interval, 0.391-0.815) was achieved in 32/50 cases. The difference between sLT and VT was -4.9 ± 15.0 W. No comparative error was noted in the Bland-Altman plot. No device-related adverse events were reported among the registered patients. Our sweat lactate sensor is safe and accurate for detecting VT in patients with HF in clinical settings, thereby offering valuable additional information for treatment.

Identifiants

pubmed: 39152287
doi: 10.1038/s41598-024-70001-9
pii: 10.1038/s41598-024-70001-9
doi:

Substances chimiques

Lactic Acid 33X04XA5AT

Types de publication

Journal Article Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

18985

Subventions

Organisme : Japan Science and Technology Corporation
ID : JPMJPF2101

Informations de copyright

© 2024. The Author(s).

Références

Schnohr, P., O’Keefe, J. H., Marott, J. L., Lange, P. & Jensen, G. B. Dose of jogging and long-term mortality: The Copenhagen city heart study. J. Am. Coll. Cardiol. 65, 411–419 (2015).
doi: 10.1016/j.jacc.2014.11.023 pubmed: 25660917
Wen, C. P. et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378, 1244–1253 (2011).
doi: 10.1016/S0140-6736(11)60749-6 pubmed: 21846575
Belardinelli, R., Georgiou, D., Cianci, G. & Purcaro, A. 10-year exercise training in chronic heart failure: A randomized controlled trial. J. Am. Coll. Cardiol. 60, 1521–1528 (2012).
doi: 10.1016/j.jacc.2012.06.036 pubmed: 22999730
Binder, R. K. et al. Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing. Eur. J. Cardiovasc. Prev. Rehabil. 15, 726–734 (2008).
doi: 10.1097/HJR.0b013e328304fed4 pubmed: 19050438
Baker, L. B. Sweating rate and sweat sodium concentration in athletes: a review of methodology and intra/interindividual variability. Sports Med. 47, 111–128 (2017).
doi: 10.1007/s40279-017-0691-5 pubmed: 28332116 pmcid: 5371639
Baker, L. B. & Wolfe, A. S. Physiological mechanisms determining eccrine sweat composition. Eur. J. Appl. Physiol. 120, 719–752 (2020).
doi: 10.1007/s00421-020-04323-7 pubmed: 32124007 pmcid: 7125257
Green, J. M., Bishop, P. A., Muir, I. H., McLester, J. R. Jr. & Heath, H. E. Effects of high and low blood lactate concentrations on sweat lactate response. Int. J. Sports Med. 21, 556–560 (2000).
doi: 10.1055/s-2000-8483 pubmed: 11156274
Lamont, L. S. Sweat lactate secretion during exercise in relation to women’s aerobic capacity. J. Appl. Physiol. 1985(62), 194–198 (1987).
doi: 10.1152/jappl.1987.62.1.194
Katsumata, Y. et al. Laminar flow ventilation system to prevent airborne infection during exercise in the COVID-19 crisis: A single-center observational study. PLoS ONE 16, e0257549 (2021).
doi: 10.1371/journal.pone.0257549 pubmed: 34758032 pmcid: 8580245
Katsumata, Y. et al. A novel device for detecting anaerobic threshold using sweat lactate during exercise. Sci. Rep. 11(1), 4929 (2021).
doi: 10.1038/s41598-021-84381-9 pubmed: 33654133 pmcid: 7925537
Okawara, H. et al. Kinetic changes in sweat lactate following fatigue during constant workload exercise. Physiol. Rep. 10, e15169 (2022).
doi: 10.14814/phy2.15169 pubmed: 35043587 pmcid: 8767313
Sawada, T. et al. Constant load pedaling exercise combined with electrical muscle stimulation leads to an early increase in sweat lactate levels. Sensors 22, 9585 (2022).
doi: 10.3390/s22249585 pubmed: 36559954 pmcid: 9784187
Maeda, Y. et al. Implications of the onset of sweating on the sweat lactate threshold. Sensors 23, 3378 (2023).
doi: 10.3390/s23073378 pubmed: 37050438 pmcid: 10098635
Nishi, I. et al. Are cardiac events during exercise therapy for heart failure predictable from the baseline variables?. Circ. J. 71, 1035–1039 (2007).
doi: 10.1253/circj.71.1035 pubmed: 17587707
Fernhall, B. Long-term aerobic exercise maintains peak VO(2), improves quality of life, and reduces hospitalisations and mortality in patients with heart failure. J. Physiother. 59, 56 (2013).
doi: 10.1016/S1836-9553(13)70149-8 pubmed: 23419918
Kim, D. H. et al. Epidermal electronics. Science 32, 838–843 (2014).
Havenith, G., Fogarty, A., Bartlett, R., Smith, C. J. & Ventenat, V. Male and female upper body sweat distribution during running measured with technical absorbents. Eur. J. Appl. Physiol. 104, 245–255 (2008).
doi: 10.1007/s00421-007-0636-z pubmed: 18064483
Tatterson, A. J., Hahn, A. G., Martini, D. T. & Febbraio, M. A. Effects of heat stress on physiological responses and exercise performance in elite cyclists. J. Sci. Med. Sport 3, 186–193 (2000).
doi: 10.1016/S1440-2440(00)80080-8 pubmed: 11104310
Bandodkar, A. J. & Wang, J. Non-invasive wearable electrochemical sensors: A review. Trends Biotechnol. 32, 363–371 (2014).
doi: 10.1016/j.tibtech.2014.04.005 pubmed: 24853270
Gao, W., Brooks, G. A. & Klonoff, D. C. Wearable physiological systems and technologies for metabolic monitoring. J. Appl. Physiol. 1985(124), 548–556 (2018).
doi: 10.1152/japplphysiol.00407.2017
Wen, L. et al. Humidity-/sweat-sensitive electronic skin with antibacterial, antioxidation, and ultraviolet-proof functions constructed by a cross-linked network. ACS Appl. Mater. Interfaces 14, 56074–56086 (2022).
doi: 10.1021/acsami.2c15876 pubmed: 36508579
Urhausen, A., Coen, B., Weiler, B. & Kindermann, W. Individual anaerobic threshold and maximum lactate steady state. Int. J. Sports Med. 14, 134–139 (1993).
doi: 10.1055/s-2007-1021157 pubmed: 8509241
Beneke, R. Methodological aspects of maximal lactate steady state-implications for performance testing. Eur. J. Appl. Physiol. 89, 95–99 (2003).
doi: 10.1007/s00421-002-0783-1 pubmed: 12627312
Faude, O., Kindermann, W. & Meyer, T. Lactate threshold concepts: How valid are they?. Sports Med. 39, 469–490 (2009).
doi: 10.2165/00007256-200939060-00003 pubmed: 19453206
Muramoto, Y. et al. Estimation of maximal lactate steady state using the sweat lactate sensor. Sci. Rep. 13, 10366 (2023).
doi: 10.1038/s41598-023-36983-8 pubmed: 37365235 pmcid: 10293173
Okawara, H. et al. Anaerobic threshold using sweat lactate sensor under hypoxia. Sci. Rep. 13, 22865 (2023).
doi: 10.1038/s41598-023-49369-7 pubmed: 38129473 pmcid: 10739691
Buono, M. J., Lee, N. V. & Miller, P. W. The relationship between exercise intensity and the sweat lactate excretion rate. J. Physiol. Sci. 60, 103–107 (2010).
doi: 10.1007/s12576-009-0073-3 pubmed: 20013328
Kamiya, K. et al. Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan—An analysis of the AMED-CHF study. Circ. J. 83, 1546–1552 (2019).
doi: 10.1253/circj.CJ-19-0241 pubmed: 31189753
Kanazawa, N., Yamada, S. & Fushimi, K. Trends in the use of cardiac rehabilitation in Japan between 2010 and 2017—An epidemiological survey. Circ. Rep. 3, 569–577 (2021).
doi: 10.1253/circrep.CR-21-0018 pubmed: 34703934 pmcid: 8492403
Ritchey, M. D. et al. Tracking cardiac rehabilitation participation and completion among medicare beneficiaries to inform the efforts of a national initiative. Circ. Cardiovasc. Qual. Outcomes 13, e005902 (2020).
doi: 10.1161/CIRCOUTCOMES.119.005902 pubmed: 31931615 pmcid: 8091573
Park, L. G., Schopfer, D. W., Zhang, N., Shen, H. & Whooley, M. A. Participation in cardiac rehabilitation among patients with heart failure. J. Card. Fail. 23, 427–431 (2017).
doi: 10.1016/j.cardfail.2017.02.003 pubmed: 28232047 pmcid: 5454027
Piepoli, M. F., Davos, C., Francis, D. P., Coats, A. J., Extra MATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328, 189 (2004).
doi: 10.1136/bmj.328.7441.711-b pubmed: 14729656
Gaskill, S. E. et al. Validity and reliability of combining three methods to determine ventilatory threshold. Med. Sci. Sports Exerc. 33, 1841–1848 (2001).
doi: 10.1097/00005768-200111000-00007 pubmed: 11689733
Mezzani, A. et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: A report from the exercise physiology section of the European association for cardiovascular prevention and rehabilitation. Eur. J. Cardiovasc. Prev. Rehabil. 16, 249–267 (2009).
doi: 10.1097/HJR.0b013e32832914c8 pubmed: 19440156
Mezzani, A. et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: A joint position statement of the European association for cardiovascular prevention and rehabilitation, the American association of cardiovascular and pulmonary rehabilitation and the canadian association of cardiac rehabilitation. Eur. J. Prev. Cardiol. 20, 442–467 (2013).
doi: 10.1177/2047487312460484 pubmed: 23104970
Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986).
doi: 10.1016/S0140-6736(86)90837-8 pubmed: 2868172

Auteurs

Yoshinori Katsumata (Y)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. goodcentury21@keio.jp.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. goodcentury21@keio.jp.

Yuki Muramoto (Y)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Noriyuki Ishida (N)

Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.

Ryo Takemura (R)

Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.

Kengo Nagashima (K)

Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.

Takenori Ikoma (T)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Naoto Kawamatsu (N)

Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Masaru Araki (M)

Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Ayumi Goda (A)

Department of Cardiovascular Medicine, Faculty of Medicine, Kyorin University, Tokyo, Japan.

Hiroki Okawara (H)

Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Tomonori Sawada (T)

Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Yumiko Kawakubo Ichihara (YK)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Osamu Hattori (O)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Koki Yamaoka (K)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Yuta Seki (Y)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Toshinobu Ryuzaki (T)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Hidehiko Ikura (H)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Daisuke Nakashima (D)

Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Takeo Nagura (T)

Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
Department of Clinical Biomechanics, Keio University School of Medicine, Tokyo, Japan.

Masaya Nakamura (M)

Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Kazuki Sato (K)

Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Yasuyuki Shiraishi (Y)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH